Worldwide clinical experience with auranofin

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical rheumatology 1984-03, Vol.3 Suppl 1 (S1), p.105-112
Hauptverfasser: Morris, R W, Cole, D S, Horton, J, Heuer, M A, Pietrusko, R G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 112
container_issue S1
container_start_page 105
container_title Clinical rheumatology
container_volume 3 Suppl 1
creator Morris, R W
Cole, D S
Horton, J
Heuer, M A
Pietrusko, R G
description
doi_str_mv 10.1007/BF03342628
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF03342628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>6432408</sourcerecordid><originalsourceid>FETCH-LOGICAL-c284t-db8bc330624fe9f1c8fd7a73c36a88e4fbfeda8c2ccc239ae02f6d714f0cbafd3</originalsourceid><addsrcrecordid>eNpFz8FLwzAUx_EgyqzTi3ehZ7H6khea5KjDqTDwongs6csLRrp2pBvT_15lQ0-_y4cffIU4l3AtAczN3RwQtaqVPRCF1Kgr57Q7FAUYAxVKZ4_FyTh-AICyTk7EpNaoNNhCXL0NuQvbFLikLvWJfFfy54pz4p643Kb1e-k32fdDTP2pOIq-G_lsv1PxOr9_mT1Wi-eHp9ntoiJl9boKrW0JEWqlI7soycZgvEHC2lvLOraRg7ekiEih8wwq1sFIHYFaHwNOxeXul_Iwjpljs8pp6fNXI6H5LW7-i3_wxQ6vNu2Swx_dJ-I36hZRZw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Worldwide clinical experience with auranofin</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Morris, R W ; Cole, D S ; Horton, J ; Heuer, M A ; Pietrusko, R G</creator><creatorcontrib>Morris, R W ; Cole, D S ; Horton, J ; Heuer, M A ; Pietrusko, R G</creatorcontrib><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/BF03342628</identifier><identifier>PMID: 6432408</identifier><language>eng</language><publisher>Germany</publisher><subject>Adult ; Anti-Inflammatory Agents - therapeutic use ; Arthritis, Rheumatoid - drug therapy ; Auranofin ; Aurothioglucose - adverse effects ; Aurothioglucose - analogs &amp; derivatives ; Aurothioglucose - therapeutic use ; Clinical Trials as Topic ; Double-Blind Method ; Female ; Gold - analogs &amp; derivatives ; Humans ; Male ; Risk</subject><ispartof>Clinical rheumatology, 1984-03, Vol.3 Suppl 1 (S1), p.105-112</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c284t-db8bc330624fe9f1c8fd7a73c36a88e4fbfeda8c2ccc239ae02f6d714f0cbafd3</citedby><cites>FETCH-LOGICAL-c284t-db8bc330624fe9f1c8fd7a73c36a88e4fbfeda8c2ccc239ae02f6d714f0cbafd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6432408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morris, R W</creatorcontrib><creatorcontrib>Cole, D S</creatorcontrib><creatorcontrib>Horton, J</creatorcontrib><creatorcontrib>Heuer, M A</creatorcontrib><creatorcontrib>Pietrusko, R G</creatorcontrib><title>Worldwide clinical experience with auranofin</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><subject>Adult</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Auranofin</subject><subject>Aurothioglucose - adverse effects</subject><subject>Aurothioglucose - analogs &amp; derivatives</subject><subject>Aurothioglucose - therapeutic use</subject><subject>Clinical Trials as Topic</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Gold - analogs &amp; derivatives</subject><subject>Humans</subject><subject>Male</subject><subject>Risk</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFz8FLwzAUx_EgyqzTi3ehZ7H6khea5KjDqTDwongs6csLRrp2pBvT_15lQ0-_y4cffIU4l3AtAczN3RwQtaqVPRCF1Kgr57Q7FAUYAxVKZ4_FyTh-AICyTk7EpNaoNNhCXL0NuQvbFLikLvWJfFfy54pz4p643Kb1e-k32fdDTP2pOIq-G_lsv1PxOr9_mT1Wi-eHp9ntoiJl9boKrW0JEWqlI7soycZgvEHC2lvLOraRg7ekiEih8wwq1sFIHYFaHwNOxeXul_Iwjpljs8pp6fNXI6H5LW7-i3_wxQ6vNu2Swx_dJ-I36hZRZw</recordid><startdate>198403</startdate><enddate>198403</enddate><creator>Morris, R W</creator><creator>Cole, D S</creator><creator>Horton, J</creator><creator>Heuer, M A</creator><creator>Pietrusko, R G</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>198403</creationdate><title>Worldwide clinical experience with auranofin</title><author>Morris, R W ; Cole, D S ; Horton, J ; Heuer, M A ; Pietrusko, R G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c284t-db8bc330624fe9f1c8fd7a73c36a88e4fbfeda8c2ccc239ae02f6d714f0cbafd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Adult</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Auranofin</topic><topic>Aurothioglucose - adverse effects</topic><topic>Aurothioglucose - analogs &amp; derivatives</topic><topic>Aurothioglucose - therapeutic use</topic><topic>Clinical Trials as Topic</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Gold - analogs &amp; derivatives</topic><topic>Humans</topic><topic>Male</topic><topic>Risk</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morris, R W</creatorcontrib><creatorcontrib>Cole, D S</creatorcontrib><creatorcontrib>Horton, J</creatorcontrib><creatorcontrib>Heuer, M A</creatorcontrib><creatorcontrib>Pietrusko, R G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morris, R W</au><au>Cole, D S</au><au>Horton, J</au><au>Heuer, M A</au><au>Pietrusko, R G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Worldwide clinical experience with auranofin</atitle><jtitle>Clinical rheumatology</jtitle><addtitle>Clin Rheumatol</addtitle><date>1984-03</date><risdate>1984</risdate><volume>3 Suppl 1</volume><issue>S1</issue><spage>105</spage><epage>112</epage><pages>105-112</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><cop>Germany</cop><pmid>6432408</pmid><doi>10.1007/BF03342628</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0770-3198
ispartof Clinical rheumatology, 1984-03, Vol.3 Suppl 1 (S1), p.105-112
issn 0770-3198
1434-9949
language eng
recordid cdi_crossref_primary_10_1007_BF03342628
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Anti-Inflammatory Agents - therapeutic use
Arthritis, Rheumatoid - drug therapy
Auranofin
Aurothioglucose - adverse effects
Aurothioglucose - analogs & derivatives
Aurothioglucose - therapeutic use
Clinical Trials as Topic
Double-Blind Method
Female
Gold - analogs & derivatives
Humans
Male
Risk
title Worldwide clinical experience with auranofin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A59%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Worldwide%20clinical%20experience%20with%20auranofin&rft.jtitle=Clinical%20rheumatology&rft.au=Morris,%20R%20W&rft.date=1984-03&rft.volume=3%20Suppl%201&rft.issue=S1&rft.spage=105&rft.epage=112&rft.pages=105-112&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/BF03342628&rft_dat=%3Cpubmed_cross%3E6432408%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/6432408&rfr_iscdi=true